Unknown

Dataset Information

0

Synthesis and Encapsulation of Ajuga parviflora Extract with Zeolitic Imidazolate Framework-8 and Their Therapeutic Action against G+ and G- Drug-Resistant Bacteria.


ABSTRACT: Infectious diseases caused by bacteria have become a public health issue. Antibiotic therapy for infectious disorders, as well as antibiotic overuse, has resulted in antibiotic-resistant bacterial strains. Zeolitic imidazolate framework-8 (ZIF-8) possesses a wide surface area, high porosity, variable functionality, and potential drug carriers. We have established a clear method for making a nanoscale APE@ZIF-8 nanocomposite agent with outstanding antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and cephalosporin-carbapenem-resistant Escherichia coli (CCREC). We present a unique approach for encapsulating molecules ofAjuga parviflora extract (APE) with ZIF-8. APE@ZIF-8 has a positive charge. By electrostatic contact with the negatively charged bacterial surface of S. aureus and E. coli, APE@ZIF-8 NPs produce reactive oxygen species (ROS) that damage bacterial cell organelles. As a result, the APE@ZIF-8 nanocomposite offers limitless application potential in the treatment of infectious disorders caused by drug-resistant gram-positive and gram-negative bacteria.

SUBMITTER: Ahanger AM 

PROVIDER: S-EPMC8772321 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4736437 | biostudies-literature
| S-EPMC10837076 | biostudies-literature
| S-EPMC6088371 | biostudies-literature
| S-EPMC2790048 | biostudies-literature
| S-EPMC8302588 | biostudies-literature
| S-EPMC8730619 | biostudies-literature
| S-EPMC5907525 | biostudies-other
| S-EPMC6856809 | biostudies-literature
| S-EPMC7325427 | biostudies-literature